Literature DB >> 21832964

Effects of oral sea buckthorn oil on tear film Fatty acids in individuals with dry eye.

Riikka L Järvinen1, Petra S Larmo, Niko L Setälä, Baoru Yang, Janne Rk Engblom, Matti H Viitanen, Heikki P Kallio.   

Abstract

PURPOSE: Evaporative dry eye is associated with meibomian gland dysfunction and abnormalities of the tear film lipids. Dry eye is known to be affected positively by intake of linoleic and γ-linolenic acids and n-3 fatty acids. Oral sea buckthorn (Hippophaë rhamnoides) (SB) oil, which contains linoleic and α-linolenic acids and antioxidants, has shown beneficial effects on dry eye. The objective was to investigate whether supplementation with SB oil affects the composition of the tear film fatty acids in individuals reporting dry eye.
METHODS: One hundred participants were randomized to this parallel, double-blind, placebo-controlled study, which 86 of them completed. The participants daily consumed 2 g of SB or placebo oil for 3 months. Tear film samples were collected at the beginning, during, and at the end of the intervention and 1 to 2 months later. Tear film fatty acids were analyzed as methyl esters by gas chromatography.
RESULTS: There were no group differences in the changes in fatty acid proportions during the intervention (branched-chain fatty acids: P = 0.49, saturated fatty acids: P = 0.59, monounsaturated fatty acids: P = 0.53, and polyunsaturated fatty acids: P = 0.16).
CONCLUSIONS: The results indicate that the positive effects of SB oil on dry eye are not mediated through direct effects on the tear film fatty acids. Carotenoids and tocopherols in the oil or eicosanoids produced from the fatty acids of the oil may have a positive effect on inflammation and differentiation of the meibomian gland cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832964     DOI: 10.1097/ICO.0b013e3182035ad9

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

Review 2.  Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis.

Authors:  Julia Prinz; Nicola Maffulli; Matthias Fuest; Peter Walter; Frank Hildebrand; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2022-08-08

3.  A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.

Authors:  Fan Yu; Min Zheng; Alice Yang Zhang; Zongchao Han
Journal:  J Control Release       Date:  2019-10-24       Impact factor: 9.776

Review 4.  West meets east: open up a dialogue on phytomedicine.

Authors:  Xiuzhu Li; Weijie Chen; Jesus Simal-Gandara; Milen I Georgiev; Hongyi Li; Hao Hu; Xu Wu; Thomas Efferth; Shengpeng Wang
Journal:  Chin Med       Date:  2021-07-19       Impact factor: 5.455

5.  Clinical Effect of Antioxidant Glasses Containing Extracts of Medicinal Plants in Patients with Dry Eye Disease: A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Won Choi; Jae Chan Kim; Won Soo Kim; Han Jin Oh; Jee Myung Yang; Jee Bum Lee; Kyung Chul Yoon
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

Review 6.  Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine.

Authors:  Jiawei Ling; Ben Chung-Lap Chan; Miranda Sin-Man Tsang; Xun Gao; Ping Chung Leung; Christopher Wai-Kei Lam; Jiang-Miao Hu; Chun Kwok Wong
Journal:  Front Med (Lausanne)       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.